North America Drug Testing Market By Drug Type (Cannabis/Marijuana, Opioids, Cocaine, Alcohol, Amphetamine & Methamphetamine, LSD and Others), By Sample Type (Urine Samples, Oral Fluid Samples, Hair Samples and Other Samples), By Product Type (Consumables, Instruments, Rapid Testing Devices and Services), By End User (Drug Testing Laboratories, Workplaces, Hospitals and Others), By Country, Growth Potential, COVID-19 Impact Analysis Report and Forecast, 2021 - 2027

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Drug Testing Market, by Drug Type
1.4.2 North America Drug Testing Market, by Sample Type
1.4.3 North America Drug Testing Market, by Product Type
1.4.4 North America Drug Testing Market, by End User
1.4.5 North America Drug Testing Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. North America Drug Testing Market by Drug Type
3.1 North America Cannabis/Marijuana Drug Testing Market by Country
3.2 North America Opioids Drug Testing Market by Country
3.3 North America Cocaine Drug Testing Market by Country
3.4 North America Alcohol Drug Testing Market by Country
3.5 North America Amphetamine & Methamphetamine Drug Testing Market by Country
3.6 North America LSD Drug Testing Market by Country
3.7 North America Other Drug Type Drug Testing Market by Country

Chapter 4. North America Drug Testing Market by Sample Type
4.1 North America Drug Testing Urine Samples Market by Country
4.2 North America Drug Testing Oral Fluid Samples Market by Country
4.3 North America Drug Testing Hair Samples Market by Country
4.4 North America Drug Testing Other Samples Market by Country

Chapter 5. North America Drug Testing Market by Product Type
5.1 North America Consumables Drug Testing Market by Country
5.2 North America Instruments Drug Testing Market by Country
5.3 North America Rapid Testing Devices Drug Testing Market by Country
5.4 North America Services Drug Testing Market by Country

Chapter 6. North America Drug Testing Market by End-use
6.1 North America Drug Testing Laboratories Drug Testing Market by Country
6.2 North America Workplaces Drug Testing Market by Country
6.3 North America Hospitals Drug Testing Market by Country
6.4 North America Others Drug Testing Market by Country

Chapter 7. North America Drug Testing Market by Country
7.1 US Drug Testing Market
7.1.1 US Drug Testing Market by Drug Type
7.1.2 US Drug Testing Market by Sample Type
7.1.3 US Drug Testing Market by Product Type
7.1.4 US Drug Testing Market by End-use
7.2 Canada Drug Testing Market
7.2.1 Canada Drug Testing Market by Drug Type
7.2.2 Canada Drug Testing Market by Sample Type
7.2.3 Canada Drug Testing Market by Product Type
7.2.4 Canada Drug Testing Market by End-use
7.3 Mexico Drug Testing Market
7.3.1 Mexico Drug Testing Market by Drug Type
7.3.2 Mexico Drug Testing Market by Sample Type
7.3.3 Mexico Drug Testing Market by Product Type
7.3.4 Mexico Drug Testing Market by End-use
7.4 Rest of North America Drug Testing Market
7.4.1 Rest of North America Drug Testing Market by Drug Type
7.4.2 Rest of North America Drug Testing Market by Sample Type
7.4.3 Rest of North America Drug Testing Market by Product Type
7.4.4 Rest of North America Drug Testing Market by End-use

Chapter 8. Company Profiles
8.1 Quest Diagnostics, Incorporated
8.1.1 Company Overview
8.1.1 Financial Analysis
8.1.2 Recent strategies and developments:
8.1.2.1 Partnerships, Collaborations, and Agreements:
8.2 Abbott Laboratories
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.6 SWOT Analysis
8.3 F. Hoffmann-La Roche Ltd.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.4 Thermo Fisher Scientific, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.6 SWOT Analysis
8.5 Siemens AG (Siemens Healthineers)
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 SWOT Analysis
8.6 Agilent Technologies, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.7 Bio-Rad laboratories, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expenses
8.8 Dragerwerk AG & Co. KGaA
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.9 Quidel Corporation
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Regional Analysis
8.9.4 Research & Development Expense
8.9.5 Recent strategies and developments:
8.9.5.1 Trials & Approvals:
8.10. Omega Laboratories, Inc.
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Product Launches and Product Expansions:
8.10.2.2 Accreditation: